ClinicalTrials.Veeva

Menu

Study With Two Coenzyme Q10 Products (Co10_2024)

U

University of Primorska

Status

Completed

Conditions

Coenzyme Q Deficiency

Treatments

Dietary Supplement: Dietary supplement - Experimental product
Dietary Supplement: Dietary supplement - Active comparator

Study type

Interventional

Funder types

Other

Identifiers

NCT06736366
Q10_2024

Details and patient eligibility

About

The randomized, open-label, two period crossover single-dose bioavailability study with two coenzyme Q10 products

Full description

The randomized, open-label, two period crossover single-dose bioavailability study with two coenzyme Q10 products will include 35 subjects who will test two different coenzyme Q10 products. Plasma concentration of coenzyme Q10 will be measured.

Enrollment

25 patients

Sex

All

Ages

50 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • subject informed consent form
  • aged between 50 and 65 years old
  • body mass for women 70± 5 kg and for men 85± 5 kg
  • non-smoking
  • healthy, without cardio-vascular diseases, diabetes, neurodegenerative diseases
  • absence of any prescribed medication during the study
  • willing to avoid a consumption of any food supplements at least 2 weeks before and during the study

Exclusion criteria

  • cardio-vascular diseases, diabetes, neurodegenerative diseases, gastrointestinal disorders, pregnancy, breast-feeding
  • intake of any food supplements within two week of the beginning of the study
  • drug or alcohol abuse

Trial design

Primary purpose

Screening

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Double Blind

25 participants in 2 patient groups

Coenzyme Q10 (ubiquinone)
Active Comparator group
Description:
Synonyms: Maltodextrin, capsule (HPMC - hydroxypropyl methyl cellulose), coenzyme Q10 (ubiquinone); Dosage: 2 capsules, total 100 mg Co-Q10
Treatment:
Dietary Supplement: Dietary supplement - Experimental product
BMT® coenzyme Q10
Experimental group
Description:
Maltodextrin, BMT® coenzyme Q10 \[maltodextrin, coenzyme Q10 (ubiquinone), stabiliser (gum arabic), corn starch, olive oil, anti-caking agent (silicon dioxide), acidity regulators (acetic acid, citric acid)\], capsule (HPMC - hydroxypropyl methyl cellulose); Dosage: 2 capsules, total 100 mg Co-Q10
Treatment:
Dietary Supplement: Dietary supplement - Active comparator

Trial contacts and locations

1

Loading...

Central trial contact

Zala Jenko Pražnikar, phD; Ana Petelin, phD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems